Geneva, 19 October 2023—The Government of Japan has granted additional funding to the Global Antibiotic Research & Development Partnership (GARDP) to support its vital work … Japan government funding supports GARDP’s efforts to counter antibiotic resistance
Osaka (Japan), Chennai (India), Geneva (Switzerland), Boston (USA), 12 September 2023—A new agreement is poised to accelerate antibiotic access for tens of thousands of patients … Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections
Geneva and Bangalore, 27 July 2023 – The Global Antibiotic Research & Development Partnership (GARDP) is joining forces with Bugworks Research Inc. (Bugworks), an innovative clinical-stage … GARDP and Bugworks join forces to accelerate development of a novel antibiotic to treat serious bacterial infections
Geneva, 8 June 2023 – A global observational study, which involved more than 3,200 newborn babies suffering from sepsis in 19 hospitals in 11 countries, … Global study highlights deaths from neonatal sepsis and steps to improve treatment
Gonorrhoea is among the three most common sexually transmitted infections, affecting men and women worldwide. Global infection rates of gonorrhoea are increasing, with 82 million … GARDP and Innoviva Specialty Therapeutics announce completion of patient recruitment for registrational phase 3 gonorrhoea treatment trial
Geneva, 22 May 2023 – The UK government has renewed its support to GARDP by investing an additional £5 million in 2023/2024 to help develop … UK Government invests £5 million in GARDP to boost antibiotic development and access
Geneva, 22 May 2023 – An international clinical trial to evaluate much-needed new antibiotic combinations for newborn babies with sepsis has started in three public … Groundbreaking clinical trial to improve treatment for newborns with life-threatening sepsis gets underway in South Africa and Kenya
Geneva, 19 May 2023 – Representatives from the European Commission’s Health Emergency Preparedness and Response Authority (HERA), WHO and GARDP met in Geneva on 11 May, … HERA, WHO and GARDP join forces to counter the growing threat of antimicrobial resistance
Geneva (Switzerland), Liverpool (United Kingdom), 9 March 2023 – The Global Antibiotic Research and Development Partnership (GARDP) and the University of Liverpool have signed … GARDP and the University of Liverpool plan to boost collaboration on AMR
ภาษาไทย Geneva (Switzerland), Bangkok (Thailand), 28 February 2023 – The Global Antibiotic Research and Development Partnership (GARDP) and Mahidol University by the Faculty of Medicine … GARDP and SICRES, part of the Faculty of Medicine Siriraj Hospital, Mahidol University, seek to strengthen clinical research for priority drug-resistant infections in Asia